VanEck Biotech ETF Rating $204.66 +0.63 (+0.31%) As of 07/24/2026 11:45 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.68Holdings in BBH have an aggregate rating of Moderate Buy based on 510 analyst ratings issued in the past year covering 24 companies (99.9% of the portfolio).BBH Aggregate Price Target$204.66High Prediction$204.66Average Prediction$204.66Low Prediction$204.66Holdings in BBH have an aggregate price target of $204.66 and a range of $204.66 to $204.66 covering 24 companies (99.9% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.05%AMGNAmgen$376.04+1.2%4.0343 of 5 stars2.43$356.62 -5.2%30Positive News13.35%GILDGilead Sciences$129.31-1.2%4.9223 of 5 stars2.86$158.33 22.4%29Analyst Downgrade8.87%VRTXVertex Pharmaceuticals$477.36+0.9%4.2753 of 5 stars2.88$559.61 17.2%25Positive News6.41%REGNRegeneron Pharmaceuticals$656.01+0.6%4.4529 of 5 stars2.70$787.88 20.1%27Trending NewsUpcoming EarningsAnalyst Forecast5.19%RVMDRevolution Medicines$189.23+0.3%1.8255 of 5 stars2.95$144.67 -23.5%22News CoveragePositive NewsAnalyst Forecast4.83%NTRANatera$261.99-1.0%3.2613 of 5 stars2.82$267.83 2.2%22Positive News4.76%ARGXargenex$918.22-0.7%4.067 of 5 stars2.92$1,050.50 14.4%24Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision4.41%IQVIQVIA$208.22+0.4%3.7131 of 5 stars2.81$225.71 8.4%16News CoveragePositive NewsUpcoming Earnings4.00%ALNYAlnylam Pharmaceuticals$271.77+1.1%4.6062 of 5 stars2.85$452.13 66.4%26News CoverageUpcoming EarningsAnalyst Forecast3.44%MRNAModerna$54.07-5.2%1.5742 of 5 stars1.82$40.00 -26.0%17Upcoming EarningsAnalyst Forecast3.29%ILMNIllumina$194.09-1.4%2.344 of 5 stars2.37$156.88 -19.2%19Trending NewsUpcoming Earnings3.27%BIIBBiogen$202.19+0.8%3.9201 of 5 stars2.53$220.57 9.1%32Upcoming EarningsAnalyst Forecast2.89%ONCBeOne Medicines$325.90-0.3%4.2677 of 5 stars2.80$394.00 20.9%15Trending NewsAnalyst Forecast2.83%INSMInsmed$106.92-0.5%3.8911 of 5 stars3.00$209.13 95.6%26Positive News2.81%UTHRUnited Therapeutics$528.47-0.2%4.697 of 5 stars2.85$648.33 22.7%13News CoveragePositive NewsAnalyst Forecast2.50%INCYIncyte$117.67+0.8%3.1786 of 5 stars2.36$111.10 -5.6%22News CoveragePositive NewsUpcoming EarningsAnalyst Forecast2.14%NBIXNeurocrine Biosciences$175.77+0.9%4.682 of 5 stars2.96$194.05 10.4%23News CoveragePositive NewsUpcoming EarningsAnalyst Forecast1.90%BNTXBioNTech$89.33-3.0%4.1865 of 5 stars2.74$129.13 44.5%191.76%ICLRIcon$165.76-2.7%2.818 of 5 stars2.25$168.73 1.8%16News CoveragePositive NewsUpcoming EarningsGap Up1.50%TECHBio-Techne$71.60-0.2%2.6704 of 5 stars2.12$68.08 -4.9%17Positive News1.44%CRLCharles River Laboratories International$226.38-1.3%2.7847 of 5 stars2.63$220.75 -2.5%16News CoveragePositive News1.36%BMRNBioMarin Pharmaceutical$59.33+0.8%4.5071 of 5 stars2.71$88.26 48.8%24News CoveragePositive News1.00%QGENQiagen$41.38-0.2%3.9593 of 5 stars2.36$43.34 4.8%14News CoveragePositive News0.94%TEMTempus AI$42.69-7.2%3.6302 of 5 stars2.44$68.92 61.5%16Upcoming EarningsAnalyst Forecast This page (NASDAQ:BBH) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | SponsoredBuy this stock tomorrowMarc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBH Stock Alerts